Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 17 May 2024

Case report: Lymph node metastasis of pelvic alveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology

in Hematologic Malignancies

Xinyu Hu
Chenxin Huang
Qiyuan Li
Baolin Wu
Chuyun Yue
Xueying Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1340865

1,563 views

Brief Research Report

Published on 17 May 2024

Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

in Hematologic Malignancies

Darrell White
Gary J. Schiller
Sumit Madan
Suzanne Lentzsch
Evgeni Chubar
Noa Lavi
Dane R. Van Domelen
Ohad S. Bentur
Muhamed Baljevic

Frontiers in Oncology

doi 10.3389/fonc.2024.1352281

4,987 views
8 citations

Review

Published on 16 May 2024

An overview of prognostic markers in patients with CLL

in Hematologic Malignancies

Julie Braish
Claudio Cerchione
Alessandra Ferrajoli

Frontiers in Oncology

doi 10.3389/fonc.2024.1371057

9,291 views
16 citations

Original Research

Published on 13 May 2024

Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients

in Hematologic Malignancies

Edoardo Benedetti
Ginevra Traverso
Giulia Pucci
Riccardo Morganti
Emilia Bramanti
Federica Cavallo
Enrico Capochiani
Maurizio De Maria
Vittorio Ricchiuto
Massimo Salvatore Stella

Frontiers in Oncology

doi 10.3389/fonc.2024.1369601

1,808 views
3 citations

Original Research

Published on 10 May 2024

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

in Hematologic Malignancies

Jin Li
Zhuxia Jia
Rongxuan Wang
Bitao Xiao
Yanan Cai
Tianshu Zhu
Weiya Wang
Xinyue Zhang
Shu Fan
Xiaolong Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1357996

1,949 views
2 citations

Review

Published on 10 May 2024

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma

in Hematologic Malignancies

Kevin Miller
Hamza Hashmi
Sridevi Rajeeve

Frontiers in Oncology

doi 10.3389/fonc.2024.1398902

11,750 views
8 citations

Brief Research Report

Published on 08 May 2024

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

in Hematologic Malignancies

Bruna Murbach
Gislaine Duarte
Leonardo Carvalho Palma
Eliana Miranda
Guilherme Duffles
Graziele Pavan Furlin
Isabella Toni
Carmino De Souza
Larissa Binelli
Vitor Leonardo Bassan

Frontiers in Oncology

doi 10.3389/fonc.2024.1393191

3,615 views

Case Report

Published on 03 May 2024

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

in Hematologic Malignancies

Annaïse J. Jauch
Ilaria Alborelli
Andreas Reusser
Albert Baschong
Cyrill Rütsche
Olivier Bignucolo
Jakob Passweg
Stefan Dirnhofer
Fatime Krasniqi

Frontiers in Oncology

doi 10.3389/fonc.2024.1296238

2,358 views
3 citations

Editorial

Published on 02 May 2024

Editorial: Reviews in hematologic malignancies: 2023

in Hematologic Malignancies

Billy Michael Chelliah Jebaraj
Michael Liew
Felix Seyfried

Frontiers in Oncology

doi 10.3389/fonc.2024.1412843

1,687 views

Original Research

Published on 02 May 2024

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

in Hematologic Malignancies

Claudia Núñez-Torrón Stock
Carlos Jiménez Chillón
Fernando Martín Moro
Juan Marquet Palomanes
Miguel Piris Villaespesa
Ernesto Roldán Santiago
Eulalia Rodríguez Martín
Anabelle Chinea Rodríguez
Valentín García Gutiérrez
Gemma Moreno Jiménez

Frontiers in Oncology

doi 10.3389/fonc.2024.1394648

2,010 views
2 citations

Case Report

Published on 02 May 2024

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

in Hematologic Malignancies

Elisa Diral
Gloria Catalano
Maria Vittoria Cicinelli
Andrea Distefano
Sara Mastaglio
Luca Vago
Maria Teresa Lupo Stanghellini
Massimo Bernardi
Maurilio Ponzoni
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2024.1399894

1,473 views

Case Report

Published on 01 May 2024

Osteolytic lesions as a presenting sign of acute myeloid leukemia: a case report

in Hematologic Malignancies

Jingqian Zhang
Shidai Mu
Li Cai
Lisha Ai
Yaohui Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364266

2,219 views
1 citation

Case Report

Published on 26 Apr 2024

A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine

in Hematologic Malignancies

Mengci Hu
Wenzhe Li
Pan Li
Jie Tan
Ya Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1329279

2,924 views
1 citation

Original Research

Published on 23 Apr 2024

Clinical efficacy of prophylactic intravenous immunoglobulin for elderly DLBCL patients with hypogammaglobulinemia in the COVID-19 pandemic era

in Hematologic Malignancies

Dong Won Baek
Ga-Young Song
Ho Sup Lee
Young Rok Do
Ji Hyun Lee
Ho-Young Yhim
Joon Ho Moon
Deok-Hwan Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1380492

2,036 views

Review

Published on 22 Apr 2024

Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing

in Hematologic Malignancies

Jianbiao Zhou
Wee-Joo Chng

Frontiers in Oncology

doi 10.3389/fonc.2024.1365330

7,833 views
6 citations

Mini Review

Published on 22 Apr 2024

Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma

in Hematologic Malignancies

Yifan Pang
Nilanjan Ghosh

Frontiers in Oncology

doi 10.3389/fonc.2024.1396395

5,034 views
2 citations